23 January 2018
News and Views
Links and Services
Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development, finds the latest Hepatology.
Statins are 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitors used for the treatment of
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors